Brandi Reeves
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Internal Medicine top 5%
Papers in
- Hematology 32
- Multiple Myeloma Research and Treatments 21
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 6
-
- Protein Degradation and Inhibitors 12
- Co-authors
- Nigel S. Key (6 shared papers)Paul G. Richardson (13 shared papers)Peter M. Voorhees (11 shared papers)Denis F. Noubouossie (1 shared paper)Brian D. Strahl (1 shared paper)Suzanne Trudel (4 shared papers)Shaker R. Dakhil (4 shared papers)Adam D. Cohen (4 shared papers)
- Journals
- Blood (13 papers)Journal of Clinical Oncology (5 papers)HemaSphere (4 papers)Blood Advances (3 papers)British Journal of Haematology (2 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Brandi Reeves
40 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 83
- Hematology 707
- Internal Medicine 100
- Oncology 688
- Genetics 195
- Dermatology 148
Countries citing papers authored by Brandi Reeves
This map shows the geographic impact of Brandi Reeves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandi Reeves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandi Reeves more than expected).
Fields of papers citing papers by Brandi Reeves
This network shows the impact of papers produced by Brandi Reeves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandi Reeves. The network helps show where Brandi Reeves may publish in the future.
Co-authors
The 25 scholars most cited alongside Brandi Reeves, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 196 | |
| 2 | 2018 | 192 | |
| 3 | 2019 | 171 | |
| 4 | 2012 | 127 | |
| 5 | 2019 | 125 | |
| 6 | 2021 | 104 | |
| 7 | 2020 | 62 | |
| 8 | 2020 | 51 | |
| 9 | 2023 | 50 | |
| 10 | 2012 | 37 | |
| 11 | 2018 | 32 | |
| 12 | 2017 | 29 | |
| 13 | 2022 | 25 | |
| 14 | 2021 | 18 | |
| 15 | 2021 | 16 | |
| 16 | 2002 | 14 | |
| 17 | 2021 | 12 | |
| 18 | 2022 | 11 | |
| 19 | 2016 | 10 | |
| 20 | 2020 | 9 |
About Brandi Reeves
Brandi Reeves is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Rheumatology, having authored 42 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (21 papers), Protein Degradation and Inhibitors (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Cancer Treatment and Pharmacology (6 papers), Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Eosinophilic Disorders and Syndromes (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Hematology (707 citations), Internal Medicine (100 citations), Oncology (688 citations), Genetics (195 citations) and Dermatology (148 citations). Brandi Reeves has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Nigel S. Key, Paul G. Richardson, Peter M. Voorhees, Denis F. Noubouossie, Brian D. Strahl, Suzanne Trudel, Shaker R. Dakhil, Adam D. Cohen, Sherry L. Wolf and Nguyet Le‐Lindqwister. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Blood Advances and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.